Oncologic Emergencies: The Clock Is Ticking

Medical College of Georgia - Augusta University

G. Raval

The TAPUR Study: Evaluating Targeted Therapies Based on Genetic Alte…

University of Miami Sylvester Comprehensive Cancer Center

R. Schilsky

Breaking Boundaries: The Science Behind Immune Tolerance in Cancer

Yale Cancer Center

M. Mamula, E. Winer

Identifying and Targeting DNA Repair Mutations in Cancer

Yale Cancer Center

S. Ganesan

T-Cell Exhaustion in Chronic Viral Infection and Cancer: Implication…

Yale Cancer Center

R. Ahmed

Blood Cancers Basics

Masonic Cancer Center, University of Minnesota

Z. Sachs

Impact of Chronic Stress on Solid Tumor Growth and Immune Response V…

Ben Switzer

Overview of HIPEC for Nurses and APPs

Total Health

I. Solsky

Therapeutic Targeting of Epigenetic Mechanisms in Cancer

Yale Cancer Center

S. Armstrong

Tumor-Infiltrating Lymphocytes for Clinicians

Houston Methodist

S. Ganguly

The Evolution of HIPEC in the Treatment of Cancer

Yale Cancer Center

K. Turaga

GESR: An Affordable Resource for Genome Edited Cell Lines, iPSC, and…

Masonic Cancer Center, University of Minnesota

C. Meiers

Inferring Therapeutic Vulnerability Within Tumors Through Integratio…

Masonic Cancer Center, University of Minnesota

R. Stephanie Huang

PARPi in DNA Repair-Associated Cancers: Predictors of Benefit, Mecha…

UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

G. Fleming

Episode 2: Principles of Neoadjuvant Therapy: Terminology, Pros and …

Emerging Treatments in Oncology Weekly

V. Sondak

Two-Hit Models to Understand the Mechanisms of Latent Doxorubicin Ca…

Masonic Cancer Center, University of Minnesota

B. Zordoky

Mechanisms of B-Cell Selection as Therapeutic Targets in Leukemia an…

Yale Cancer Center

M. Muschen

Managing Chemo Side Effects in Cancer Care: What Are the Tactics for…

Dr. Michelle Gardiner

B-Cell Selection as Therapeutic Targets in Leukemia and Lymphoma: Ta…

Yale Cancer Center

M. Muschen

Mediating Anticancer Drug Resistance: What Are the New Players?

The Asian Oncology Society 1st Virtual International Conference

R. Ankathil